NBS 49 Markers

Support comprehensive early newborn health assessment with the NBS 49 Markers test at Lucid Medical Diagnostics. This advanced newborn screening panel evaluates 49 selected biochemical markers to help screen for a broad range of inherited metabolic disorders and congenital conditions during the early stages of life. Expanded neonatal screening can provide valuable information for identifying babies who may require timely follow-up, clinical evaluation, and confirmatory diagnostic testing. Screening results are not a definitive diagnosis and should be interpreted by qualified healthcare professionals alongside the infant’s clinical history and appropriate follow-up investigations. At Lucid Medical Diagnostics, advanced laboratory technology, standardized testing procedures, and experienced professionals help deliver accurate, dependable results for newborn screening and early clinical assessment.

Home Sample Collection Available
Get Reports